Brief: Aequus Posts Q3 Revenue Of $291,154
29/11/2017 21:15
Nov 29 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS PHARMACEUTICALS- REVENUE FOR CURRENT QUARTER WAS
$291,154, A 56% INCREASE COMPARED TO REVENUES OF $186,586 IN
IMMEDIATELY PRECEDING Q2 OF 2017
Source text for Eikon: ID:nCCNW2gKla
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange